“…The currently available driver lines to target conditional alleles in the NP cells are the non-inducible Noto Cre (McCann et al, 2012), Shh Cre (Harfe et al, 2004), and Foxa2 Cre (Uetzmann et al, 2008) alleles, or tamoxifen-inducible Agc1 CreERT2 (Henry et al, 2009), Col2a1 CreERT2 (Chen et al, 2007), and Col2a1 CreER (Nakamura et al, 2006). And the Noto Cre (Bedore et al, 2013; McCann et al, 2012), Shh Cre (Winkler et al, 2014; Wu et al, 2013), Foxa2 Cre (Merceron et al, 2014; Uetzmann et al, 2008), Agc1 CreERT2 (Alkhatib et al, 2018; Alvarez-Garcia et al, 2018; Henry et al, 2009; Liao et al, 2019; Novais et al, 2019) and Col2a1 CreERT2 (Chen et al, 2007; Zheng et al, 2018) alleles have been employed to understand the development, regulation and aging of the mouse NP cells in the IVD. However, none of these driver lines are appropriate to target NP cells during the postnatal stages due to the constraint of spatial and temporal regulation of their action, and specificity to NP cells.…”